Evidence map›Paper›PMID 41547863›Full record

ArticleHarm reduction journal2026

Clinical outcomes from a mid-western opioid treatment program during covid-19 emergency regulations: a brief report on the effect of tetrahydrocannabinol (THC) use on take home methadone access.

Erin T LaCourt, Oranu Ibekie, Charles C Dike, Oluwole Jegede

Abstract read
In one paragraph

Article in Harm reduction journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Erin T LaCourtVictory Clinical Services, 4218 W. Western Avenue, South Bend, IN, 46619, USA. vcserin@gmail.com.
Oranu IbekieIndiana University School of Medicine, Victory Clinical Services, 4218 W. Western Avenue, South Bend, IN, 46619, USA.
Charles C DikeDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT, 06519, USA.ORCID 0000-0002-9510-5088
Oluwole JegedeDepartment of Psychiatry, Yale University School of Medicine, 34 Park Street, New Haven, CT, 06519, USA.ORCID 0000-0001-6772-7149

Funding

Cultural Adaptation of Contingency Management for adults with Stimulant Use DisorderK23DA063650 · NIDA · YALE UNIVERSITY · PI Oluwole Olugbenga Jegede · 2025 to 2026
$390k
Connecticut Department of Mental Health and Addiction Services n/aNIDA NIH HHS K23 DA063650NIDA NIH HHS K23DA063650
6 · The paper itself

Abstract

The study examines whether tetrahydrocannabinol (THC) use alone affected sustainability of weekly take-home methadone medication among a small sample of 33 patients attending a single opioid treatment program, under special exception by state and federal governments during the Covid-19 pandemic. Kaplan Meier analyses of survival rates in months of eligibility for take-home methadone showed that the majority of patients with continuing THC use remained eligible for 10 months despite continued THC use. Majority were employed, insured, and housed stably, but Log Rank Tests on these predictor variables showed no statistical significance. The socioeconomic stability of the cohort may indicate THC use alone may be less important in restricting take-home methadone and warrants further research.

Indexed as

Analgesics, OpioidCOVID-19DronabinolMethadoneOpiate Substitution TreatmentOpioid-Related DisordersAdultFemaleHumansMaleMiddle AgedTreatment OutcomeAnalgesics, OpioidDronabinolMethadoneMethadone take-homeOpioid use disorderTetrahydrocannabinolTHCTreatment engagement

Identifiers

PMID41547863
PMCPMC12895690

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.